15/01/2016
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
The Parc Tecnològic del Vallès (PTV) is the oldest technology park in Spain (1987). PTV can be considered as the initial phase of a more global project of a territory designed to attract innovative companies in the environment of the Universitat Autònoma de Barcelona. This project has matured with the second phase corresponding to the creation of the Barcelona Synchrotron Park (BSP) around the ALBA synchrotron operative since 2012.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
More news
13/04/2023
Panattoni acquires 60,000 sqm land plot to build a data center
16/09/2021
Battery technology in the Barcelona Synchrotron Park environment
06/09/2021
Advances in the creation of a state-of-the-art microscopy platform at the Alba Synchrotron
22/07/2021
IBM, the big blue of technology at the Barcelona Synchrotron Park
02/07/2021
SENER, cutting-edge engineering and technology in the Barcelona Synchrotron Park
11/06/2021
Parc de l'Alba: first injection of landfill gas into the distribution network
home